Quantbot Technologies LP Illumina, Inc. Transaction History

Quantbot Technologies LP

$2.5 Billion
Q4 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$101.05 - $133.57 $1.35 Million - $1.79 Million	13,396 New	13,396 $1.4 Million
Q3 2023 Nov 07, 2023	BUY	$128.91 - $192.44 $355,920 - $531,326	2,761 New	2,761 $379,000
Q2 2022 Aug 09, 2022	BUY	$181.58 - $368.0 $5.09 Million - $10.3 Million	28,047 New	28,047 $5.17 Million
Q1 2022 May 16, 2022	SELL	$303.87 - $423.8 $4.19 Million - $5.84 Million	-13,780 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$347.28 - $421.83 $136,481 - $165,779	-393 Reduced 2.77%	13,780 $5.24 Million
Q3 2021 Nov 09, 2021	BUY	$405.61 - $524.84 $5.75 Million - $7.44 Million	14,173 New	14,173 $5.75 Million
Q2 2021 Aug 12, 2021	SELL	$372.84 - $481.5 $4.31 Million - $5.57 Million	-11,558 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$361.28 - $504.76 $3.36 Million - $4.7 Million	9,306 Added 413.23%	11,558 $4.44 Million
Q4 2020 Feb 12, 2021	BUY	$292.7 - $370.96 $659,160 - $835,401	2,252 New	2,252 $833,000
Q1 2019 May 13, 2019	SELL	$272.57 - $321.18 $1.69 Million - $1.99 Million	-6,200 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$272.46 - $366.54 $1.69 Million - $2.27 Million	6,200 New	6,200 $1.86 Million
Q3 2018 Nov 13, 2018	SELL	$279.04 - $367.06 $425,256 - $559,399	-1,524 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$228.17 - $292.07 $536,655 - $686,948	-2,352 Reduced 60.68%	1,524 $425,000
Q1 2018 May 11, 2018	BUY	$209.54 - $253.91 $812,177 - $984,155	3,876 New	3,876 $916,000
Q4 2017 Feb 12, 2018	SELL	$202.23 - $230.03 $536,718 - $610,499	-2,654 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$172.3 - $213.93 $457,284 - $567,770	2,654	2,654 $528,000

Others Institutions Holding ILMN

# of Institutions

968

Shares Held

151M

Call Options Held

2.37M

Put Options Held

1.41M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $14.8B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.

Account